Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Miller

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Experimental Neurology|May 28, 2013
Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis modelMatthew J Crisp, Jeffrey Beckett, Joan R Coates, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 2, 2022
Antisense Oligonucleotides for the Study and Treatment of ALSBenjamin D Boros, Kathleen M Schoch, Collin J Kreple, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2008
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondriaChristine Vande Velde, Timothy M Miller, Neil R Cashman, et al.
Scientific Reports|March 20, 2020
CNS microRNA profiles: a database for cell type enriched microRNA expression across the mouse central nervous systemNathan Pomper, Yating Liu, Mariah L Hoye, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2009
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationIga Wegorzewska, Shaughn Bell, Nigel J Cairns, et al.
Muscle & Nerve|March 7, 2026
Integrating Serum Neurofilament Light Chain Into Amyotrophic Lateral Sclerosis Diagnostic CriteriaSean E Smith, Timothy M Miller, Andrew Atkinson, et al.
Contemporary Clinical Trials|May 7, 2024
Bringing platform trials closer to reality by enabling with digital research environment (DRE) connectivityJeffrey S Barrett, Kara Lasater, Scott Russell, et al.
Annals of Neurology|June 28, 2006
Progressive spinal axonal degeneration and slowness in ALS2-deficient miceKoji Yamanaka, Timothy M Miller, Melissa McAlonis-Downes, et al.
Muscle & Nerve|August 11, 2023
Lumbar punctures are safe in patients with ALS and have a risk profile similar to that in the non-ALS populationCollin J Kreple, Saivaroon Gajagowni, Jennifer Jockel-Balsaratti, et al.
American Journal of Medical Genetics. Part A|September 3, 2013
Timing of diagnosis of patients with Pompe disease: data from the Pompe registryPriya S Kishnani, Hernán M Amartino, Christopher Lindberg, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Experimental Neurology|May 28, 2013
Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis modelMatthew J Crisp, Jeffrey Beckett, Joan R Coates, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 2, 2022
Antisense Oligonucleotides for the Study and Treatment of ALSBenjamin D Boros, Kathleen M Schoch, Collin J Kreple, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2008
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondriaChristine Vande Velde, Timothy M Miller, Neil R Cashman, et al.
Scientific Reports|March 20, 2020
CNS microRNA profiles: a database for cell type enriched microRNA expression across the mouse central nervous systemNathan Pomper, Yating Liu, Mariah L Hoye, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2009
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationIga Wegorzewska, Shaughn Bell, Nigel J Cairns, et al.
Muscle & Nerve|March 7, 2026
Integrating Serum Neurofilament Light Chain Into Amyotrophic Lateral Sclerosis Diagnostic CriteriaSean E Smith, Timothy M Miller, Andrew Atkinson, et al.
Contemporary Clinical Trials|May 7, 2024
Bringing platform trials closer to reality by enabling with digital research environment (DRE) connectivityJeffrey S Barrett, Kara Lasater, Scott Russell, et al.
Annals of Neurology|June 28, 2006
Progressive spinal axonal degeneration and slowness in ALS2-deficient miceKoji Yamanaka, Timothy M Miller, Melissa McAlonis-Downes, et al.
Muscle & Nerve|August 11, 2023
Lumbar punctures are safe in patients with ALS and have a risk profile similar to that in the non-ALS populationCollin J Kreple, Saivaroon Gajagowni, Jennifer Jockel-Balsaratti, et al.
American Journal of Medical Genetics. Part A|September 3, 2013
Timing of diagnosis of patients with Pompe disease: data from the Pompe registryPriya S Kishnani, Hernán M Amartino, Christopher Lindberg, et al.
Pageof 13